key: cord-0861590-9lbe71ui
authors: Miyazato, Yusuke; Ishikane, Masahiro; Inada, Makoto; Ohmagari, Norio
title: Acute portal vein thrombosis with COVID-19 and cirrhosis
date: 2021-03-27
journal: IDCases
DOI: 10.1016/j.idcr.2021.e01094
sha: 91d75aa896f898c4a05618afeb529d4c57406ea9
doc_id: 861590
cord_uid: 9lbe71ui

nan

A 67-year-old Japanese man with diabetes, alcohol-related cirrhosis, and esophageal varices was transferred to our hospital with fever and respiratory distress. On admission, he was diagnosed with severe COVID-19 due to hypoxemia. He received nasal high-flow oxygen treatment (40 L/min), remdesivir, and dexamethasone. On hospital day (HD) 5, his D-dimer level was elevated to 7.3 mg/mL, but we did not administer anticoagulants because of his history of ruptured esophageal varices. On HD 12, contrast-enhanced CT showed portal vein thrombosis extending from the superior mesenteric vein to the main trunk of the portal vein ( Fig. 1) , which had not been detected on plain CT on the day of admission, and anticoagulation was initiated immediately.

Patients with COVID-19 sometimes develop both arterial and venous thrombosis [1] . COVID-19 may also be associated with portal vein thrombosis [2, 3] . Observational studies suggest that anticoagulation in COVID-19 patients with D-dimer levels >3.0 mg/ mL may be associated with lower mortality rates [4] . However, the decision to start anticoagulants needs to be carefully considered in COVID-19 patients with a high bleeding risk, such as a history of ruptured esophageal varices, as in this case. 

Written informed consent was obtained from the patient for publication of this case report and accompanying images.

Written informed consent was obtained from the patient for publication of this case report and accompanying images.

Conceptualization: Yusuke Miyazato, Masahiro Ishikane. Data curation: Yusuke Miyazato, Masahiro Ishikane, Makoto Inada.

Formal analysis: Yusuke Miyazato, Masahiro Ishikane. Supervision: Norio Ohmagari. All authors contributed to the writing of the final manuscript.

The authors report no declarations of interest.

Incidence of thrombotic complications in critically ill ICU patients with COVID-19

Portal vein thrombosis in a patient with COVID-19

Acute portal vein thrombosis in SARS-CoV-2 infection: a case report

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

We thank Dr. Masatoshi Hotta, Department of Radiology, National Center for Global Health and Medicine, Japan, for the analysis of contrast-enhanced CT images, and all the clinical staff at the National Center for Global Health and Medicine for their dedicated clinical practice and patient care.